Development asset linked to Option Therapeutics in public FDA and regional records.
pharma · Autoimmune Epilepsy · OPTN
Option Therapeutics
Option Therapeutics drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
CARSON CITY, NV, USA HQ
2023 Founded
2 Employees
Public company Type
OPTN · NYSE Ticker
Company details
- Status
- Public
- HQ
- CARSON CITY, NV, USA
- Founded
- 2023
- Employees
- 2
- Programs
- 1
- Drugs
- 1
- Patents
- 10
Option Therapeutics pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Option Therapeutics drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.